A cancer care management device which aims to protect patients from a potentially lethal side effect of chemotherapy has raised £1 million in funding. 52 North Health, a UK- and US-based MedTech startup, is developing the NeutroCheck – a fully-integrated clinical, AI- and medical device-based system for people living with cancer.  The NeutroCheck is a … Continue reading £1m for ‘life-saving’ cancer care management device